Comparative effectiveness and cardiovascular safety of abaloparatide and teriparatide in postmenopausal women new to anabolic therapy: A US administrative claims database study

Cosman, F., Cooper, C., Wang, Y., Mitlak, B., Varughese, S., & Williams, S. A. (2022). Comparative effectiveness and cardiovascular safety of abaloparatide and teriparatide in postmenopausal women new to anabolic therapy: A US administrative claims database study. Osteoporosis International, 33(8), 1703–1714. https://doi.org/10.1007/s00198-022-06413-y
Authors:
F Cosman
C Cooper
Y Wang
B Mitlak
S Varughese
S A Williams
Affiliated Authors:
F Cosman
Columbia Affiliation:
Subjects:
Bone Density Conservation Agents (MeSH)
Hip Fractures (MeSH)
Osteoporosis, Postmenopausal (MeSH)
Osteoporotic Fractures (MeSH)
Author Keywords:
osteoporosis
abaloparatide
nonvertebral fractures
comparative effectiveness
administrative claims
teriparatide
elink
Publication Type:
Article
Unique ID:
10.1007/s00198-022-06413-y
PMID:
35524068
DOI:
10.1007/s00198-022-06413-y
Journal:
Osteoporosis International
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Web of Science Record

Record Created: